Skip to main content
. 2022 Feb 9;13:774. doi: 10.1038/s41467-022-28437-y

Fig. 4. The molecular subtypes are associated with response to immune checkpoint inhibitors.

Fig. 4

Patients with advanced gastric cancer who were treated with immune checkpoint blockade were stratified by molecular subtypes. Response is defined by complete response (CR) or partial response (PR). Non-response is defined as stable disease (SD) or progressive disease (PD). The chi-square test was used to compare groups. Source data are provided as a source data file.